Endocyte ( ECYT) is a biopharmaceutical company. The company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. Yesterday's Volume: 293,400 Average Volume: 151,305 Volume % Change: 55% From a technical standpoint, this stock is very close to triggering a big breakout trade if it can manage to sustain a move and close above its 200-day moving average of $10.60 on volume that's close to or above its three-month average action of 151,305 shares. If we see that action, then traders should watch for ECYT to trend back toward $12 to $13.50. To see more stocks rising on unusual volume, including ADA-ES ( ADES), Ebix ( EBIX) and Madison Square Garden ( MSG), check out the Stocks Rising On Unusual Volume portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.